Akums Drugs & Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Strong revenue growth in the latest quarter indicates effective product launches and market expansion strategies.
Improved gross margins suggest better cost management and pricing power amidst competitive pressures.
Increased R&D investment positions the company well for future innovations and market opportunities.

NEGATIVES

Rising raw material costs are impacting profit margins, reflecting challenges in the supply chain.
Sales growth has slowed compared to previous quarters, raising concerns about sustaining momentum.
Increasing debt levels could pressure future cash flows and limit financial flexibility.

Field	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	1,019.11	1,033.09	1,010.41	1,024.03
Expenses	938.18	958.67	938.70	955.12
Operating Profit	80.93	74.42	71.71	68.91
Other Income	6.55	13.47	14.56	26.73
Interest	13.02	11.90	5.13	23.13
Depreciation	34.06	34.86	44.52	36.92
Profit Before Tax	87.48	91.59	91.05	95.65
Tax	26.27	24.93	24.74	30.96
Net Profit	61.21	66.65	66.31	64.69
Eps in Rs	4.21	4.37	4.26	4.15